Regulatory news Normativa europea 4 aprile 2025 Schema europeo di qualità per lo screening e il trattamento del cancro della mammella
Regulatory news / Area Liver 26 marzo 2025 Distribution and prevalence of fungemia: a five-year retrospective multicentric survey in Venetian region, Italy
Prodotti GS / Area HIV 14 marzo 2025 Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Prodotti competitors / Area Onco-Ema, Area Kite 28 febbraio 2025 Columvi (glofitamab) : CHMP opinion on variation to marketing authorisation in relapsed or refractory diffuse large B-cell lymphoma
Prodotti competitors / Area Oncology 28 febbraio 2025 Enhertu (trastuzumab deruxtecan): CHMP opinion on variation to marketing authorisation in HR-positive HER2-low or -ultralow breast cancer
Prodotti competitors / Area HIV 14 febbraio 2025 APRETUDE Reimbursement Milestones in Scotland and Canada
Prodotti competitors / Area Oncology 31 gennaio 2025 Positive CHMP Opinion for Datopotamab Deruxtecan (Datroway) for the 2L+ treatment of unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer
Prodotti competitors / Area HIV 31 gennaio 2025 Discontinuation of a paediatric development plan for the J&J candidates for prevention of human immunodeficiency virus (HIV-1) infection
Regulatory news Normativa europea 28 ottobre 2024 Carenze di medicinali: la strategia UE per garantire la sicurezza sanitaria
Prodotti competitors 11 ottobre 2024 Lancet: Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension
